Assistance Publique - Hôpitaux de Paris: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trials
The registry lists 15 Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 6Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.Not yet recruitingNCT07451847Phase 4
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT07077304
- Epithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisRecruitingNCT07010250
- A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO TrialRecruitingNCT05946564Phase 3
- Study of Salvage Therapy to Treat Patients With Granulomatosis With PolyangiitisRecruitingNCT04871191Phase 3
- Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic PolyangiitisCompletedNCT03920722Phase 3
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 2
- Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab TherapyCompletedNCT03069703Phase 2
- Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated VasculitisStatus unknownNCT02463578
- Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated VasculitisCompletedNCT02463539
- Comparison Between a Long Term and a Conventional Maintenance Treatment With RituximabCompletedNCT02433522Phase 3
- Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)CompletedNCT01862068
- Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated VasculitisCompletedNCT01731561Phase 3
- Efficacy Study of Two Treatments in the Remission of VasculitisCompletedNCT00748644Phase 3